Apomeds is an online pharmacy service operating in Europe, they provide online diagnoses (via partner brand) and quick home delivery of prescription and over-the-counter drugs.
One of the main sources of revenue for the company is the sale of ED treatments for men (VIagra …) The company provides branded medicine from known providers such as Pfizer and Lilly and their equivalent more generic substitutes - the generic ones are significantly cheaper and there is a business incentive to sale them instead of the branded ones - the company may offer a better price and even cut a bigger margin when selling these products.
Apomeds customers trust and prefer mostly branded products when given the choice and mostly try to buy them and not the generic ones. Therefore, they miss the chance for greater value for their money and the company misses in cutting a bigger margin.
Limitation:
Regulation-wise we we are not allowed to market RX medicine say that one product is better than the other in its effects, or give it a description beyond what was sanctioned by EU health authorities.
The entity that provides Medical service (Diagnosis in our case) Cannot be the same one who Sales the treatment (Pharmacy)